DOWLING & YAHNKE LLC - TRACON PHARMACEUTICALS INC ownership

TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 34 filers reported holding TRACON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.

Quarter-by-quarter ownership
DOWLING & YAHNKE LLC ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$79,000
-16.8%
47,4550.0%0.00%0.0%
Q2 2022$95,000
-24.0%
47,4550.0%0.00%
-20.0%
Q1 2022$125,000
-4.6%
47,4550.0%0.01%
-16.7%
Q4 2021$131,000
-16.6%
47,455
+17.3%
0.01%
-33.3%
Q3 2021$157,000
-40.3%
40,4550.0%0.01%
-40.0%
Q2 2021$263,000
-21.0%
40,4550.0%0.02%
-34.8%
Q1 2021$333,000
-6.5%
40,455
+32.8%
0.02%
-8.0%
Q4 2020$356,000
+126.8%
30,4550.0%0.02%
+92.3%
Q3 2020$157,000
+292.5%
30,455
+48.9%
0.01%
+333.3%
Q2 2020$40,000
+53.8%
20,455
+36.4%
0.00%0.0%
Q1 2020$26,00015,0000.00%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,518,371$9,746,0001.82%
Altium Capital Management LP 785,341$3,039,0000.80%
Ikarian Capital, LLC 2,691,110$10,415,0000.73%
Telemetry Investments, L.L.C. 130,500$505,0000.68%
Psagot Value Holdings Ltd. 143,591$556,0000.10%
Psagot Value Holdings Ltd. / (Israel) 143,591$556,0000.10%
ACT CAPITAL MANAGEMENT, LLC 28,500$110,0000.06%
X-Square Capital, LLC 17,973$70,0000.04%
GSA CAPITAL PARTNERS LLP 85,993$333,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 268,301$1,038,0000.03%
View complete list of TRACON PHARMACEUTICALS INC shareholders